BitcoinSistemi
2025-07-16 17:04:07

Nasdaq-Listed Company Signs Agreement to Buy This Altcoin: Happening for the First Time

US-based and NASDAQ-listed Windtree Therapeutics has taken a significant step in its crypto asset strategy, signing a $60 million investment agreement with Build and Build Corp. The agreement includes the potential for an additional subscription of up to $140 million. This investment, which could reach a total of $200 million, will enable Windtree to directly own BNB, making it the first company in this category on NASDAQ. According to a press release from the company, the investment proceeds will be in the form of cash, shares of the Osprey BNB Chain Trust, and direct BNB tokens. This funding will be used to launch Windtree's BNB-focused cryptocurrency treasury strategy and purchase BNB. Following final closing and shareholder approvals, the company will become the first NASDAQ company to offer direct exposure to the BNB token, which has a market capitalization exceeding $95 billion. Related News: Prominent Analyst Katie Stockton Commented on Bitcoin and XRP Price The new strategy aims to implement a comprehensive BNB Crypto Treasury Strategy that includes custody services, security, and yield generation. “We are thrilled to introduce a pioneering BNB strategy to the US market,” said Patrick Horsman, Director of Build & Build Corp. “This innovative solution fills a significant gap in the US investment landscape by providing investors with targeted exposure to Binance and BNB.” *This is not investment advice. Continue Reading: Nasdaq-Listed Company Signs Agreement to Buy This Altcoin: Happening for the First Time

Get Crypto Newsletter
Read the Disclaimer : All content provided herein our website, hyperlinked sites, associated applications, forums, blogs, social media accounts and other platforms (“Site”) is for your general information only, procured from third party sources. We make no warranties of any kind in relation to our content, including but not limited to accuracy and updatedness. No part of the content that we provide constitutes financial advice, legal advice or any other form of advice meant for your specific reliance for any purpose. Any use or reliance on our content is solely at your own risk and discretion. You should conduct your own research, review, analyse and verify our content before relying on them. Trading is a highly risky activity that can lead to major losses, please therefore consult your financial advisor before making any decision. No content on our Site is meant to be a solicitation or offer.